Esperion Therapeutics
ESPR
#8331
Rank
โ‚น14.35 B
Marketcap
โ‚น72.55
Share price
-10.32%
Change (1 day)
-54.44%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): โ‚น0.61 Billion

According to Esperion Therapeutics's latest financial reports the company's current earnings are โ‚น0.33 Billion. , an increase over its 2023 earnings that were of -โ‚น12.8 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น0.63 B-104.99%
2023 -โ‚น12.8 Billion-15.03%
2022 -โ‚น15.06 Billion-20.61%
2021 -โ‚น18.97 Billion84.28%
2020 -โ‚น10.3 Billion35.75%
2019 -โ‚น7.59 Billion-55.71%
2018 -โ‚น17.13 Billion19.57%
2017 -โ‚น14.32 Billion125.39%
2016 -โ‚น6.36 Billion51.43%
2015 -โ‚น4.2 Billion36.45%
2014 -โ‚น3.08 Billion43.55%
2013 -โ‚น2.15 Billion145.26%
2012 -โ‚น0.88 Billion
2002 -โ‚น2.49 Billion-7.81%
2001 -โ‚น2.71 Billion15.03%
2000 -โ‚น2.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น42.97 Billion-6,821.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น46.13 B 7,117.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น946.27 B 147,954.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น407.00 B 63,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น2.45 Billion-483.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น17.07 Billion-2,769.90%๐Ÿ‡บ๐Ÿ‡ธ USA